Braun Stacey Associates’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-251,255
Closed -$13.1M 136
2021
Q1
$13.1M Sell
251,255
-53,180
-17% -$3.23M 0.55% 91
2020
Q4
$13.4M Buy
304,435
+9,823
+3% +$468K 0.6% 81
2020
Q3
$14M Buy
294,612
+56,947
+24% +$2.31M 0.75% 63
2020
Q2
$7.19M Buy
237,665
+50,175
+27% +$1.12M 0.41% 96
2020
Q1
$3.2M Sell
187,490
-3,005
-2% -$52.6K 0.24% 97
2019
Q4
$3.13M Sell
190,495
-4,130
-2% -$61.5K 0.17% 100
2019
Q3
$3.18M Buy
+194,625
New +$3.9M 0.2% 96

Other funds holding CYRX

Braun Stacey Associates's CYRX Position: Q2 2021 in Review

Braun Stacey Associates sold out of CryoPort (CYRX) in Q2 2021, closing a stake of 251,255 shares — an estimated $13.1M sold.

Braun Stacey Associates first reported a position in CYRX in Q3 2019 and held it in 7 quarters. The position peaked at $14M in Q3 2020. 211 funds tracked by Wall St. Rank hold CYRX as of Q2 2021.

  • Braun Stacey Associates reported no remaining CryoPort position as of Q2 2021 after selling out during the quarter.
  • Braun Stacey Associates sold 251,255 CryoPort shares in Q2 2021, an estimated $13.1M.
  • Braun Stacey Associates first reported a position in CryoPort in Q3 2019 and held it in 7 quarters.
  • Braun Stacey Associates's CryoPort position peaked at $14M in Q3 2020.
  • 211 funds tracked by Wall St. Rank held CryoPort as of Q2 2021.

Based on Braun Stacey Associates's 13F filing for Q2 2021, filed 23 Jul 2021.